BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33211089)

  • 1. Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation.
    Marklund A; Lundberg FE; Eloranta S; Hedayati E; Pettersson K; Rodriguez-Wallberg KA
    JAMA Oncol; 2021 Jan; 7(1):86-91. PubMed ID: 33211089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis.
    Marklund A; Lekberg T; Hedayati E; Liljegren A; Bergh J; Lundberg FE; Rodriguez-Wallberg KA
    JAMA Oncol; 2022 Oct; 8(10):1438-1446. PubMed ID: 36006625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assisted reproductive technology use and outcomes among women with a history of cancer.
    Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ
    Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis.
    Xu Z; Ibrahim S; Burdett S; Rydzewska L; Al Wattar BH; Davies MC
    Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():41-48. PubMed ID: 36535069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study.
    Machtinger R; Fallach N; Goldstein I; Chodick G; Schiff E; Orvieto R; Mashiach R
    Hum Reprod; 2022 Mar; 37(3):577-585. PubMed ID: 34871410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective and Onco-fertility preservation: factors related to IVF outcomes.
    Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
    Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of oocytes associated with maximum cumulative live birth rates per aspiration depends on female age: a population study of 221 221 treatment cycles.
    Law YJ; Zhang N; Venetis CA; Chambers GM; Harris K
    Hum Reprod; 2019 Sep; 34(9):1778-1787. PubMed ID: 31398253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
    Kanbar M; de Michele F; Giudice MG; Desmet L; Poels J; Wyns C
    Hum Reprod; 2021 Jan; 36(1):26-39. PubMed ID: 33259629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to cancer treatment and reproductive outcomes after fertility preservation among adolescent and young adult women with cancer.
    Meernik C; Engel SM; Baggett CD; Wardell A; Zhou X; Ruddy KJ; Wantman E; Baker VL; Luke B; Mersereau JE; Cai J; Olshan AF; Smitherman AB; Nichols HB
    Cancer; 2023 Jan; 129(2):307-319. PubMed ID: 36316813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
    Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
    Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
    Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophin stimulation and risk of relapse in breast cancer.
    Fredriksson A; Rosenberg E; Einbeigi Z; Bergh C; Strandell A
    Hum Reprod Open; 2021; 2021(1):hoaa061. PubMed ID: 33501382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility preservation in patients of childbearing age treated for breast cancer: A nationwide cohort study.
    Duraes M; Rathat G; Bringer-Deutsch S; Ranisavljevic N; Brouillet S; Defez-Fougeron C; Duflos C
    Breast; 2022 Aug; 64():121-126. PubMed ID: 35661841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
    Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
    Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.
    Lind T; Holte J; Olofsson JI; Hadziosmanovic N; Gudmundsson J; Nedstrand E; Lood M; Berglund L; Rodriguez-Wallberg K
    Hum Reprod; 2018 Feb; 33(2):238-247. PubMed ID: 29211889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of fertility preservation in breast cancer patients in a register-based matched cohort study.
    Rodriguez-Wallberg KA; Eloranta S; Krawiec K; Lissmats A; Bergh J; Liljegren A
    Breast Cancer Res Treat; 2018 Feb; 167(3):761-769. PubMed ID: 29098528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.